Log In
Print this Print this

MIN-117, Wf-516

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionAntagonist of serotonin (5-HT2A) and serotonin (5-HT) transporter (SLC6A4; SERT) receptors and inhibitor of both serotonin and dopamine reuptake
Molecular Target Serotonin (5-HT2A) receptor ; Serotonin (5-HT) transporter (SLC6A4) (SERT)
Mechanism of ActionSerotonin (5-HT1A) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsTreat depression; Treat major depressive disorder (MDD)
Regulatory Designation
PartnerMinerva Neurosciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today